United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · IEX Real-Time Price · USD
329.16
+0.49 (0.15%)
At close: Jul 19, 2024, 4:00 PM
334.02
+4.86 (1.48%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
United Therapeutics Revenue
United Therapeutics had revenue of $2.50B in the twelve months ending March 31, 2024, with 26.09% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $677.70M with 33.70% year-over-year growth. In the year 2023, United Therapeutics had annual revenue of $2.33B with 20.20% growth.
Revenue (ttm)
$2.50B
Revenue Growth
+26.09%
P/S Ratio
5.85
Revenue / Employee
$2,138,955
Employees
1,168
Market Cap
14.60B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.33B | 391.20M | 20.20% |
Dec 31, 2022 | 1.94B | 250.80M | 14.88% |
Dec 31, 2021 | 1.69B | 202.20M | 13.63% |
Dec 31, 2020 | 1.48B | 34.50M | 2.38% |
Dec 31, 2019 | 1.45B | -179.00M | -11.00% |
Dec 31, 2018 | 1.63B | -97.50M | -5.65% |
Dec 31, 2017 | 1.73B | 126.50M | 7.91% |
Dec 31, 2016 | 1.60B | 133.00M | 9.07% |
Dec 31, 2015 | 1.47B | 177.30M | 13.76% |
Dec 31, 2014 | 1.29B | 171.52M | 15.36% |
Dec 31, 2013 | 1.12B | 200.91M | 21.93% |
Dec 31, 2012 | 916.08M | 172.89M | 23.26% |
Dec 31, 2011 | 743.18M | 150.28M | 25.35% |
Dec 31, 2010 | 592.90M | 234.02M | 65.21% |
Dec 31, 2009 | 358.88M | 77.38M | 27.49% |
Dec 31, 2008 | 281.50M | 70.55M | 33.45% |
Dec 31, 2007 | 210.94M | 51.31M | 32.14% |
Dec 31, 2006 | 159.63M | 43.72M | 37.71% |
Dec 31, 2005 | 115.92M | 42.33M | 57.51% |
Dec 31, 2004 | 73.59M | 20.25M | 37.96% |
Dec 31, 2003 | 53.34M | 23.22M | 77.09% |
Dec 31, 2002 | 30.12M | 24.39M | 425.56% |
Dec 31, 2001 | 5.73M | 3.68M | 179.70% |
Dec 31, 2000 | 2.05M | 1.61M | 369.42% |
Dec 31, 1999 | 436.50K | 382.75K | 712.08% |
Dec 31, 1998 | 53.75K | -62.16K | -53.63% |
Dec 31, 1997 | 115.91K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Molina Healthcare | 35.85B |
Viatris | 15.36B |
Quest Diagnostics | 9.29B |
Incyte | 3.77B |
Revvity | 2.73B |
BioMarin Pharmaceutical | 2.47B |
Neurocrine Biosciences | 1.98B |
Medpace Holdings | 1.96B |
UTHR News
- 12 days ago - United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis - Business Wire
- 23 days ago - Big Money Elevating United Therapeutics - FXEmpire
- 25 days ago - United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors - Business Wire
- 6 weeks ago - United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference - Business Wire
- 2 months ago - United Therapeutics Corporation Reports First Quarter 2024 Financial Results - Business Wire
- 3 months ago - CORRECTING and REPLACING PHOTO United Therapeutics Announces World's First Successful Xenothymokidney Transplant - Business Wire
- 3 months ago - United Therapeutics Announces World's First Successful Xenothymokidney Transplant - Business Wire
- 3 months ago - United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024 - Business Wire